Details for Patent: 9,138,432
✉ Email this page to a colleague
Title: | Methods for the administration of iloperidone |
Abstract: | The present invention relates to methods for treating a patient with iloperidone or a metabolite thereof, which patient is also being treated with fluoxetine, and lowering risk for QT prolongation. |
Inventor(s): | Wolfgang; Curt (Germantown, MD), Polymeropoulos; Mihael (Potomac, MD) |
Assignee: | Vanda Pharmaceuticals, Inc. (Washington, DC) |
Filing Date: | Jan 08, 2014 |
Application Number: | 14/150,575 |
Claims: | 1. A method of decreasing a risk of QT prolongation in a patient being treated for schizophrenia with iloperidone, the method comprising: administering to the patient a dose of iloperidone that is 24 mg/day if, and because, the patient is not being treated with fluoxetine; and administering to the patient a dose of iloperidone that is 12 mg/day if, and because, the patient is being treated with fluoxetine. |